Global Isotopes

Global Isotopes is a leading international supplier and distributor of medical and industrial radioisotopes, operating as the commercial arm of NTP Radioisotopes SOC Ltd, a subsidiary of the South African Nuclear Energy Corporation (Necsa). The company is a cornerstone of the global nuclear medicine industry, providing a significant percentage of the world's supply of Molybdenum-99 (Mo-99), which is essential for diagnostic imaging in cardiology and oncology. Beyond Mo-99, Global Isotopes distributes a range of therapeutic and diagnostic products, including Iodine-131 for thyroid conditions and Lutetium-177 for targeted radionuclide therapy. The company manages complex global logistics to deliver short-lived radioactive materials from its production base at the SAFARI-1 reactor to healthcare facilities and pharmaceutical partners worldwide. Its commitment to using Low Enriched Uranium (LEU) for isotope production highlights its role in promoting global nuclear security while meeting critical healthcare needs.